fbpx

YOUR GUIDE TO STAYING INFORMED IN THE MARKETS

Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Merck Appoints Cristal N. Downing To Newly Created Role Of Chief Communications & Public Affairs Officer

By John F. Heerdink, Jr.

As per reports, Merck & Co., Inc. (MRK) has appointed Cristal N. Downing as the chief communications & public affairs officer, a newly created role, effective August 16, 2021. Downing will lead the advancement, development, and execution of the company’s communications and public affairs strategy and will also be a member of Merck’s Executive Team.

Most recently, Downing was VP, Communications & Public Affairs, Medical Devices, at Johnson & Johnson, prior to which Downing held the role of vice president, Global Finance Communications at Johnson & Johnson. She has more than 20 years of leadership capabilities and expertise working in complex and diverse organizations, including JP Morgan Chase, American Express, and Wells Fargo.

Rob Davis, CEO, and president, Merck, stated “Cristal is a transformational leader with a well-established track record of achievement. Cristal’s experience, business acumen, leadership capabilities and integrity will be invaluable as we drive productive conversations and strategic impact with a broad range of stakeholders, double down on our promising pipeline and work to accelerate delivery of our vital innovations to the world.”


Merck & Co., Inc. (MRK) is a global healthcare solutions provider that has been working towards bringing forward medicine and vaccines for some of the world’s most challenging diseases for more than a century. They are committed to increasing health care access and continue to be at the leading edge of research. Merck has the industry’s largest immuno-oncology clinical research program. To learn more about Merck (MRK) and to track its ongoing progress please visit the Vista Partners Merck Coverage Page.


If you liked this story please consider, visiting the Atossa Therapeutics (ATOS) dedicated page at Vista Partners to learn about the Seattle-based biotech firm’s work towards finding therapeutic treatments for Breast Cancer and the Coronavirus. 

Stay Informed! Stay Competitive! Please join us at Vista Partners and receive our FREE email updates throughout the week and view our exclusive content and research. Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.

(Read Original Story: Merck Announces Appointment of Cristal N. Downing as Chief Communications & Public Affairs Officer in Business Wire)


YOUR GUIDE TO STAYING INFORMED IN THE MARKETS

Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Connect with us